Goldman Sachs’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,183,198
Closed -$4.97M 5329
2023
Q1
$4.97M Sell
1,183,198
-16,875
-1% -$70.9K ﹤0.01% 2553
2022
Q4
$7.21M Sell
1,200,073
-335,471
-22% -$2.02M ﹤0.01% 2357
2022
Q3
$8.94M Buy
1,535,544
+887,948
+137% +$5.17M ﹤0.01% 2220
2022
Q2
$3.87M Buy
647,596
+298,421
+85% +$1.78M ﹤0.01% 2891
2022
Q1
$1.63M Buy
349,175
+288,128
+472% +$1.35M ﹤0.01% 3724
2021
Q4
$152K Buy
+61,047
New +$152K ﹤0.01% 5096
2021
Q3
Sell
-41,558
Closed -$104K 5753
2021
Q2
$104K Buy
+41,558
New +$104K ﹤0.01% 5112
2021
Q1
Sell
-57,586
Closed -$185K 5549
2020
Q4
$185K Buy
+57,586
New +$185K ﹤0.01% 4301
2020
Q1
Sell
-13,131
Closed -$21K 4679
2019
Q4
$21K Buy
+13,131
New +$21K ﹤0.01% 4254
2019
Q3
Sell
-379,279
Closed -$326K 4451
2019
Q2
$326K Buy
+379,279
New +$326K ﹤0.01% 3692
2019
Q1
Sell
-11,272
Closed -$8K 4370
2018
Q4
$8K Sell
11,272
-4,936
-30% -$3.5K ﹤0.01% 4053
2018
Q3
$35K Sell
16,208
-66,530
-80% -$144K ﹤0.01% 4048
2018
Q2
$412K Sell
82,738
-340,216
-80% -$1.69M ﹤0.01% 3604
2018
Q1
$1.65M Buy
+422,954
New +$1.65M ﹤0.01% 2965
2017
Q3
Sell
-23,412
Closed -$77K 4590
2017
Q2
$77K Sell
23,412
-27,943
-54% -$91.9K ﹤0.01% 4187
2017
Q1
$216K Sell
51,355
-62,441
-55% -$263K ﹤0.01% 3927
2016
Q4
$464K Sell
113,796
-23,743
-17% -$96.8K ﹤0.01% 3492
2016
Q3
$515K Sell
137,539
-11,514
-8% -$43.1K ﹤0.01% 3423
2016
Q2
$507K Buy
149,053
+137,005
+1,137% +$466K ﹤0.01% 3316
2016
Q1
$64K Sell
12,048
-20,303
-63% -$108K ﹤0.01% 4152
2015
Q4
$398K Buy
32,351
+5,193
+19% +$63.9K ﹤0.01% 3367
2015
Q3
$396K Sell
27,158
-23,061
-46% -$336K ﹤0.01% 3447
2015
Q2
$979K Buy
50,219
+14,949
+42% +$291K ﹤0.01% 2962
2015
Q1
$638K Sell
35,270
-23,438
-40% -$424K ﹤0.01% 3166
2014
Q4
$1.39M Buy
58,708
+13,461
+30% +$318K ﹤0.01% 2730
2014
Q3
$1.1M Buy
45,247
+5,042
+13% +$122K ﹤0.01% 2846
2014
Q2
$1.13M Sell
40,205
-5,989
-13% -$168K ﹤0.01% 2901
2014
Q1
$1.57M Sell
46,194
-40,049
-46% -$1.36M ﹤0.01% 2710
2013
Q4
$1.65M Buy
86,243
+82,647
+2,298% +$1.58M ﹤0.01% 2768
2013
Q3
$58K Buy
3,596
+638
+22% +$10.3K ﹤0.01% 4086
2013
Q2
$31K Buy
+2,958
New +$31K ﹤0.01% 3931